Article Details
Retrieved on: 2023-01-10 03:16:11
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
(Bloomberg) -- AstraZeneca Plc agreed to buy US biotech CinCor Pharma Inc. for as much as $1.8 billion to gain a promising new treatment for ...
Article found on: www.bnnbloomberg.ca
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here